Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk

Launched by UNIVERSITY OF MONASTIR · Aug 22, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the occurrence of venous thrombosis, which is a condition where blood clots form in the veins of the legs, in patients who have been hospitalized for more than 48 hours due to serious medical issues, such as heart failure or cancer. The goal is to understand how common this problem is after patients leave the hospital and to identify factors that might increase the risk of developing these blood clots. This information is important because it can help doctors decide on the best preventive measures for patients at risk.

To be eligible for this study, participants must be adults aged 40 and older who were hospitalized for more than two days for an acute medical condition. They should also be at risk for developing blood clots due to factors like limited movement, a history of clotting disorders, or being overweight. Participants will undergo screening for venous thrombosis after their hospital discharge. If you or a loved one are considering participation, it’s important to know that the study is currently recruiting and aims to gather valuable insights that could improve care for patients in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients included adults aged at least 40 years old
• • hospitalized for more than 48 hours for an acute medical illness (i.e. heart failure, active cancer, acute ischemic stroke, infectious diseases, inflammatory disease and respiratory failure acute)
• • patients at risk of MIVT due to moderate or severe immobility, history of thrombophilia (factor C or S deficiency, etc.), body mass index of 30 kg/m2.
• Exclusion Criteria:
• • hospitalised for less than 48
• • patients who required intensive care, patients with cognitive impairment, patients admitted for SARS-CoV-2 infection or patients with a hospital stay \<2 days, patients with a pre-existing reason for anticoagulation (therapeutic), such as atrial fibrillation or ETD and patients in whom MIVT is discovered on first ultrasound examination upon discharge from hospital.